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A B S T R A C T   
Disease registry systems provide a strong information infrastructure for decision-making and research. The 
purpose of this study is to describe the implementation method and protocol of the COVID-19 registry in Khu-
zestan province, Iran. We established a steering committee and formulated the purposes of the registry. Then, 
based on reviewing the literature, and expert panels, the minimum data set, the data collection forms and the 
web-based software were developed. Data collection is done retrospectively through Hospital Information Sys-
tems, Medical Care Monitoring Center system (MCMC), Management of Communicable Disease Prevention and 
Control system (MCDPC) as well as, patients’ records. For prospective data collection, the data collection forms 
are compiled with patients’ medical records by the medical staff and are then entered into the registry system. 
We collect patients’ administrative and demographic data, history and physical examinations, test and imaging 
results, disease progression, treatment, outcomes, and follow-ups of the confirmed and suspected inpatients and 
outpatients. From April 20 to December 5, 2020, the data of 4,812 confirmed cases and 7,113 suspected cases 
were collected from two COVID-19 referral hospitals. Based on our experience, recording information along with 
providing care for patients and putting patients’ data registration in the medical staff’s routine, structuring data, 
having a flexible technical team and rapid software development for multiple and continuous updates, auto-
mating data collection by connecting the registry to existing information systems and having different incentives, 
the registration process can be strengthened.   
1. Introduction 
The COVID-19 pandemic is a global health crisis of our time and the 
greatest challenge humanity has encountered since World War II [1]. 
Even though 63 different vaccines are undergoing clinical trials on 
humans and vaccinations have begun in some countries, it is still a long 
way from complete control of the pandemic [2]. From the beginning of 
the COVID-19 pandemic, various countries have realized that access to 
accurate, complete, actionable, reliable, and timely data plays a vital 
role to effectively manage the outbreak [3]. Access to information helps 
policymakers facilitate the prioritization of care, monitoring the disease 
outbreak situation, trends, progress, and performance of health systems 
for disease control [3–5]. Furthermore, access to quality information 
also plays an important role in supporting research [6]. Therefore, all 
over the world, governments, research centers, universities, medical 
centers, etc. have collected COVID-19 data through programs such as the 
development or improvement of national information systems, infor-
mation dashboards, data hubs, datasets, and COVID-19 -related regis-
tration systems [7–13]. 
Iran was one of the first countries in the world which faced a wide-
spread outbreak of COVID-19 and has one of the highest mortality rates 
compared to the number of diagnosed cases [14,15]. In Iran, before the 
COVID-19 pandemics, the SIB and hospital information systems (HIS) 
were the two major systems for documenting health data in healthcare 
centers, the first one is used to collect primary health care data in urban 
and rural health centers and the second one is for collecting outpatients 
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and inpatients data in hospitals, respectively. However, due to the 
critical need for real-time COVID-19 patient data, from the beginning of 
the COVID-19 pandemic, the Ministry of Health set up two web-based 
information systems to report COVID-19 cases. The two systems 
included the Medical Care Monitoring Center system (MCMC) for 
reporting COVID-19 cases in hospitals and the Management of 
Communicable Disease Prevention and Control (MCDPC) system for 
reporting COVID-19 cases from primary healthcare centers [16]. 
Although the two systems collect primary data about COVID-19 
cases, there are several important issues regarding the adequacy of 
data for COVID-19 research. First, the key issue with COVID-19 is the 
unknown and unpredictability of many aspects of the disease. Despite 
much research on COVID-19, there are still many questions among re-
searchers about the disease [17,18]. Therefore, there is a need for a 
comprehensive information system to collect all available data on all 
aspects of this disease. The second issue is data quality. The low quality 
of COVID-19 data limits its usefulness to conduct studies [19]. Although 
no specific study has been done on the quality of data in the two 
mentioned information systems, some studies and reports indicate 
problems in collecting and reporting COVID-19 data in Iran [20,21]. 
A systematic approach to data quality control is not envisaged in the 
two information systems. The issue of poor data quality in the COVID-19 
epidemic crisis is a problem in many countries around the world 
[22–25]. One of the approaches that can help systematically collect data 
on a specific disease considering the data quality control process is a 
disease registry system. The disease registries and databases constitute 
key instruments to develop clinical research [26]. In the disease registry 
systems, patients with a specific disease are systematically recorded and 
analyzed in a predefined population. Therefore, these systems can create 
a real-world view of the disease, disease outcomes, safety, and the 
effectiveness of treatment methods [26]. Therefore, the implementation 
of the COVID-19 registration system can help to systematically data 
collection for researches [27]. 
Khuzestan province in the south of Iran is one of the provinces with 
the highest number of COVID-19 cases. Therefore, implementing the 
COVID-19 registry in this province provides the opportunity to identify 
the prevalence and extent of the outbreak, complications, and treatment 
outcomes. Hence, from the beginning of the outbreak in this province, a 
regional COVID-19 registry program has been established. In this study, 
we describe the measures taken to set up this COVID-19 registry system 
in Khuzestan in southwestern Iran. Implementing the COVID-19 registry 
provides the opportunity to identify the prevalence and extent of the 
outbreak, early and late complications of the disease, and factors 
affecting response to treatment, and outcomes. Furthermore, according 
to the COVID-19 vaccination program, registration systems may help 
investigate the side effects of vaccines and their effectiveness in large 
populations. In the following sections, we described the purpose and 
protocol of this registry as well as lessons learned from pilot 
implementation. 
2. Registry purpose and objectives 
The main purpose of this registry is to prepare a database of patients 
with COVID-19 to determine the prevalence and the incidence of the 
disease and to perform medical research. In this regard, the steering 
committee considered the following objectives for this program:  
1. Epidemiological studies on the incidence and prevalence of COVID- 
19  
2. Determining the underlying factors affecting the severity of COVID- 
19  
3. Determining the complications and outcomes among patients with 
COVID-19  
4. Identifying the outcomes of interventions and treatment methods 
used for patients with COVID-19  
5. Determining the individual and social factors (age, sex, occupation, 
education, etc.) in patients with COVID-19  
6. Determining the prevalence of complications caused by COVID-19 in 
patients  
7. Determining the long-term complications of COVID-19  
8. Determining the effect of underlying diseases on the outcome of the 
patients with COVID-19  
9. Determining the causes of differences in patients’ response to 
treatment 
3. Protocol of the registry implementation 
3.1. Registry governance structure 
To establish this registry, we firstly identified stakeholders in the 
province and then formed a steering committee. The steering committee 
consists of 10 experts with different specialties, including health infor-
mation management, computer science, epidemiology, infectious dis-
ease, lung diseases, emergency medicine, and radiology. This committee 
is responsible to formulate the registry purposes and develop action 
plans and the protocol for the implementation of the program, evaluate 
the implementation of the program and seek supports. Four sub-
committees have also been established to carry out the activities of the 
program. The information management committee is responsible to 
develop data sets, data dictionaries, data collection forms, and registry 
software. The data quality assessment and analysis committee was 
formed for evaluating data quality, providing feedbacks for data 
collection, and data analysis, finally the imaging data committee is 
responsible for developing the data needed to manage imaging infor-
mation, as well as, image interpretation. Besides, the hospital executive 
committee was established under the supervision of the executive di-
rector of the registry with the responsibility of making arrangements 
with the hospitals for data collection (Fig. 1). 
3.2. Registry design and population 
In this observational study, patients’ data are recorded both retro-
spectively and prospectively. Since the establishment of the registry 
(April 2020), all outpatients and inpatients diagnosed or treated 
throughout healthcare facilities in Khuzestan province, according to the 
inclusion and exclusion criteria, are registered. Patients who have been 
diagnosed or treated before the start of the program were also retro-
spectively registered. 
Khuzestan province (see Fig. 2) is located in the southwest of Iran 
and with a population of 4,700,000 people is the fifth most populated 
province of the country. Khuzestan province has 27 towns and 54 cities 
[28]and its health care system is managed by four universities of med-
ical sciences: Ahvaz Jundishapur, Abadan, Behbahan, and Shushtar. The 
present study was first performed as a pilot in hospitals affiliated to 
Ahvaz Jundishapur University of Medical Sciences, in Ahvaz city (the 
capital of Khuzestan province). Then, based on participation agree-
ments, healthcare centers affiliated with other medical universities will 
also be involved in the registry. 
3.3. The registry inclusion and exclusion criteria 
In this registry, all confirmed suspected inpatients and outpatients 
with COVID-19 are registered according to the following inclusion 
criteria:  
• Outpatients or hospitalized patients referred in one of the healthcare 
facilities in Khuzestan province or the residents of Khuzestan prov-
ince who diagnosed or treated in other provinces;  
• Positive results for Polymerase Chain Reaction (PCR) or high clinical 
suspicion for COVID-19 based on signs and symptoms based on 
physicians’ diagnosis 
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The exclusion criteria included a negative test for COVID-19 (nega-
tive PCR) and having no clinical symptoms of COVID-19. 
3.4. Data set and data collection forms 
To prepare the initial data set, we reviewed electronic or paper-based 
COVID-19 data collection and reporting forms [29–31], patients’ med-
ical record forms, COVID-19 diagnosis guidelines of the Ministry of 
Health in Iran, other guidelines on acute respiratory infections caused by 
corona viruses, available studies on COVID-19, structure, protocol and 
minimum data set of similar disease registration systems in Iran, as well 
as data elements of related health information systems in Iran, 
mentioned in Table 1. Table 2 shows the information sources used to 
develop the data set. 
To finalize the data set, we considered the opinions of the experts in 
the field. To this end, we conducted several expert panel discussion 
sessions. Table 3 shows the characteristics of the experts involved in 
designing the minimum data set. In these meetings, the clinical experts 
Fig. 1. The governance of the Khuzestan COVID-19 registry.  
Fig. 2. Map of Khuzestan province and counties.  
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and the members of the steering committee discussed the initial version 
of the data set. For each data element, the feasibility of data collection 
(based on the indicators, such as the availability or accessibility of the 
data), the standard definition, the data format (for example, free text, 
multiple-choice, etc.), reliable data sources for collecting data, method 
of data collection (patient interview, review of test results, images, etc.) 
and the time of data collection (at the time of admission, or during the 
hospitalization period) were discussed. All data items with more than 
50% of agreement between panelists were included in the final data set. 
We, based on the results of the experts’ opinions, developed the first 
version of the COVID-19 data set, data dictionary, data collection forms, 
and registry software. In the next step, we piloted the program for three 
weeks in one of the COVID-19 referral hospitals in Ahvaz. The purpose of 
the pilot was to evaluate the structure and the content of the data 
collection forms, determine required data elements, identify new in-
formation requirements, evaluate the feasibility of data collection in the 
real environment, and determine the appropriate approach for data 
collection. 
The final data set of our COVID-19 registry system consists of seven 
top data classes including administrative data (39 data elements), dis-
ease and encounter data (65 data elements), medical history and phys-
ical examination (121 data elements), findings of clinical diagnostic 
tests (95 data elements), disease progression and outcome of treatment 
(39 data elements), medical diagnosis and cause of death (14 data ele-
ments), and follow-up data (23 data elements). Most of these data items 
are coded (to select from a drop-down menu) and only nine of them are 
free text. Furthermore, 45 data elements as minimum data sets are 
compulsory. 
We organized these data items in five data collection forms including 
basic data, medical history and physical examination, laboratory and 
imaging findings at the time of admission, disease progression and 
outcome as well as follow-up forms. 
3.5. Registry software 
Based on our COVID-19 data set, we developed web-based registry 
software using the Rapid Application Development (RAD) technique. In 
this system, an electronic record containing administrative and clinical 
data about the admission, diagnosis, treatment, and follow-ups of the 
patients is created for each patient. This software was developed using 
the NET programming language and is available at Covid.ajums.ac.ir 
(Figs. 3 and 4). 
3.6. Data collection methods 
In Khuzestan province, similar to the rest of Iran, depending on the 
population and COVID-19 epidemic situation, one or more hospitals 
(mainly affiliated to the Universities of Medical Sciences) are considered 
as COVID-19 referral centers in each city. In addition to hospitals, there 
are some health centers (known as 16-h centers) for diagnosing and PCR- 
Table 1 
The specifications of two information systems of the Ministry of Health for 
recording and reporting of COVID-19 data.  
Health information system Deputy in charge of 
system and place of 
recording and 
reporting of data 
Data elements related to 
COVID-19 
Medical Care Monitoring 




Patient identification data, 
Phone, and address,- 
Admission data, The name 
of the hospital, Early signs 
and symptoms of the 
disease, CT Scan, PaO2 
(Saturation, Underlying 
conditions, and 
comorbidity, COVID-19 test 
result, Intubation, 
Hospitalization in intensive 
care unit (ICU), Outcome, 
Date of discharge or death 
Management of 
Communicable Disease 





Patient identification data, 
Healthcare center 
identification data, Phone 
and address, Occupation, 
Direct contact with an 
infected person, Admission 
data, Signs and symptoms of 
the disease, Underlying 
conditions, and 
comorbidity- Covid19 
screening result, drugs, 
Disease complications 
(Pneumonia and respiratory 
distress syndrome, 
Outcome, Date of discharge 
or death  
Table 2 
The main information sources used to design the data set.  
Information resources Details 
Articles We searched PubMed and Google using the terms 
“COVID-19′′ and “SARS-CoV-2′′ to retrieve 
related articles 
COVID-19 data collection and 
reporting forms 
To retrieve COVID-19 data collection and 
reporting forms, we searched Google using the 
following terms in Persian and English: “COVID- 
19′′ , “SARS-COV-2′′ and “Coronavirus disease” in 
combination with the terms “data collection 
form”, “data gathering form”, “minimum data 
set”, “data set”, “data dictionary”, 
“questionnaire” and “form”. Besides, we 
requested information from other hospitals, 
universities, or researchers in Iran for forms that 
were not available by Internet 
Patient medical record Some COVID-19 patients; medical records in one 
hospital in Ahvaz were reviewed. The structure 
and content (data elements) of paper-based forms 
of medical records and data recorded in these 
forms were considered 
Health information systems Content (data elements and their values) were 
examined in the following health information 
systems in Iran: MCMC system, MCDPC, SIB, HIS 
Disease registry documents Data sets, software, protocols and guidelines of 
other current registration systems in Ahvaz 
University of Medical Sciences were examined 
Guidelines for other acute 
respiratory infections in Iran 
The previous instructions and forms of the 
Ministry of Health of Iran were reviewed for other 
acute respiratory infections caused by corona 
viruses such as severe acute respiratory syndrome 
(SARS) and the Middle East respiratory syndrome 
(MERS), and Influenza  
Table 3 
Characteristics of participants in the expert panel.  
Demographic characteristics Frequency Percent 
Sex Male 5 50 
Female 5 50 
Education PhD 3 30 
Medical Specialist 3 30 
Fellowship 4 40 
Specialty Pulmonology 3 30 
Infectious disease 1 10 
Internal medicine 1 10 
Cardiology 1 10 
Health information management 1 10 
Epidemiology 1 10 
Laboratory Science 1 10 
Emergency medicine 1 10  
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testing for ambulatory and mild cases of the disease. In hospitals, the 
data of admitted patients are recorded in paper-based medical records 
and the HIS. Furthermore, according to the instruction of the Ministry of 
Health, all confirmed and suspected cases of COVID-19 should be 
recorded and reported in the MCMC system. Data of patients referred to 
16-h centers are recorded in the MCDPC system. 
Therefore, case finding is done retrospectively and prospectively. 
The retrospective method is for patients who are admitted to the 
participant healthcare centers before the implementation of the registry. 
For retrospective case finding and data collection, since the basic data 
about these patients was available in both MCMC and MCDPC systems, 
we received a report of patients registered in these two systems. To 
control the quality of this data, we compared the recorded data for each 
patient in both systems to detect and correct any inconsistencies and 
missing data. Then, we imported the demographic data (such as the 
address and the telephone), signs and symptoms of the disease, infor-
mation about the contacts, date of symptom onset, date of admission, 
comorbidities, type of admission (outpatient, hospitalized), method of 
testing and PCR test results into the COVID-19 registry software. To 
complete the data, we actively collect information related to the medi-
cations, laboratory findings, disease progression using HIS, and patients’ 
medical records. 
In the prospective method, all data collection forms are provided for 
the participant facilities. These forms are completed like other forms of 
the patients’ medical records during hospitalization. Test results, med-
ications, and ICD-10 codes are also imported from HIS. To facilitate data 
collection and increase data quality, the people in charge of data entry 
into the registry software were selected from the staff of the same fa-
cility. The criteria for selecting the staff were having at least a bachelor’s 
degree in one of the fields of medical or paramedical sciences, interest in 
medical studies, and full-time employment in the relevant facility. A 
financial contract was signed with all these individuals to participate in 
the registry program. 
3.7. Data quality and quality assurance 
We developed several preventive, detective, and corrective actions 
adopted from literature to ensure data quality [32]. Table 4 shows our 
measures for these three-controls. The purpose of these measures is to 
Fig. 3. The Login page of the COVID-19 registry software.  
Fig.4 . A sample screenshot of the COVID-19 registry software that shows the laboratory data section. The right panel of this figure shows the other groups of data 
such as demographics, encounter data, comorbidities, Chest X-ray, CT scan, EKG findings, outcomes, Follow-ups, ICD codes, medications, and attachments. 
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minimize data errors and ensure that data collection is in accordance 
with the objectives of the registry. 
Until December 5, 2020, as a result of the data quality control pro-
cess, 158 duplicate cases were identified and excluded. Additionally, 
1955 data inconsistencies in the recorded data (such as first and last 
name, father’s name, age, address, mobile, and telephone number, 
admission and discharge data, admission ward, signs and symptoms at 
the time of admission, underlying conditions and comorbidity, admis-
sion date, discharge date, length of stay, and outcome), 9189 missing 
data (such as signs and symptoms at the time of admission, underlying 
conditions, and comorbidity, discharge date, PCR test result, outcome) 
and 1102 data errors (such as ICD-10 miscoding, misspelling, invalid 
national ID, mobile and phone number) were recognized and corrected. 
3.8. Patient follow-up 
All outpatients and hospitalized patients discharged from the 
healthcare facilities are followed-up during a period of three months for 
the outcomes of the disease. The aim is to identify patients with the 
reoccurrence of the disease, deaths after discharge, and subsequent 
consequences of the disease. Using the unique national ID of the pa-
tients, the A feature for reporting the patients’ readmission and death in 
subsequent admissions were developed in the software. Our mechanism 
to follow-up patients is to review the reports of MCDPC and MCMC 
systems to identify the subsequent admissions of patients. The data 
quality assessment and analysis committee reviews the registered pa-
tients in the reports of MCDPC and MCMC systems so that in case of a 
referral to other healthcare facilities or death, this information is 
updated in the registry software. 
3.9. Implementation of the registry 
To implement the registry, we first developed the registry protocol, 
which includes instructions and the method of data collection, follow- 
ups, exclusion of the patients, and the quality control of the informa-
tion. Then, data collection staff in one of the hospitals were trained. The 
registration process was piloted for three weeks in this COVID-19 
referral hospital in Ahvaz. Based on the feedback and experiences 
gained from the pilot, paper forms, the electronic systems, and regis-
tration protocols were updated based on the new problems and needs. It 
should be noted that in October, based on the feedback from the initial 
data analysis and pilot study, we reviewed the data set and removed 26 
data elements, and added 12 new data elements to the forms and 
software. 
After the initial phase of the pilot, the implementation phase of the 
registration program was performed. At this stage, the registration 
program was implemented in two hospitals in Ahvaz, which are 
considered as the main hospitals for COVID-19 patients. To expand the 
registry, the steering committee decided to officially communicate with 
four universities of medical sciences in Khuzestan province, as well as, 
healthcare facilities and invite them to participate. So that after the 
initial data sharing and confidentiality agreement, and signing the 
contract of cooperation, these centers and physicians will participate in 
the registry and receive the forms, privileged access to the electronic 
system, and the registration protocol. Implementation of the program 
began on April 20, and on December 5, 4,812 confirmed and 7,113 
suspected cases were registered. 
3.10. Data analysis plans 
Following the objectives of the registry program, we implemented 
various features for reporting information in the electronic system. Data 
analysis will be done following the objectives of the registry and based 
on the conventional methods of descriptive and inferential statistics. 
Registry outputs will be provided to managers, policymakers, and re-
searchers in the form of reports and other written outputs. 
3.11. Ethics approval 
This study received ethical approvals from the Ethics Research 
Committee of Ahvaz Jundishapur University of Medical Sciences (IR. 
AJUMS.REC.1399.061). 
4. Lessons learned from the implementation 
Khuzestan is one of the biggest provinces in Iran with most cases of 
COVID-19. Due to its diverse geographical and cultural conditions, the 
province faces many problems in fighting with COVID-19 [33,34]. 
Implementation of the COVID-19 registry under the supervision of the 
educational and health authorities of this province can provide access to 
quality information to deal with COVID-19 and perform medical studies 
on this disease. 
The implementation of the pilot program has resulted in lessons that 
can be learned as a model for starting other similar registry programs. 
One of the primary goals of this program was to record the patients’ 
lifestyle and nutrition and its effect on the complications and outcomes 
of the disease. However, pilot implementation of the program based on 
the designed forms and data set showed that it was not possible to collect 
patients’ lifestyle, and nutrition data in the real environment, because, 
in the routines of taking information from the patients, collecting these 
data is not a usual practice of physicians. Studies have shown that the 
separation of the data collection process or data entry from the daily 
routine processes of the clinical teams is one of the serious hindrances in 
the implementation of registry programs [35]. Also, concerning the 
appearance of the data collection forms and the method of arranging 
data elements, the pilot experiences showed that these forms should be 
Table 4 
The data quality control measures in the COVID-19 registry system.  
The general approach to 
data quality control 
Measures are taken to control the quality of data 
Preventive actions  • Developing a registry guideline for all staff  
• Training registrars and data entry staff  
• Using structured (coded) data in the registry 
software  
• Using the patient’s national ID as the unique 
identifier in the registry software  
• Developing a data dictionary for the registry 
software  
• Developing data validation rules and checks in 
software (including Data-type check, Simple range 
and constraint check, Cross-reference, and data 
consistency check)  
• In the registry software, essential data were 
considered mandatory.  
• Integrating patient data from different sources in 
the registry software  
• Recruiting registrars from the staff of the same 
healthcare center participating in the registry  
• Selecting one of the staff of each healthcare center 
as the supervisor of the registration program in the 
same center  
• Establishing the data quality assessment and 
analysis committee for developing data quality 
guidelines 
Detective actions  • Comparing data obtained from a variety of sources 
and systems to identify and correct inconsistencies, 
missing data, and duplicate cases  
• Continuous monitoring of data to identify 
abnormal and suspicious data, for example, 
unusual trend and frequency of registered cases 
from each participating centers 
Corrective actions  • Continuous correcting errors based on the results of 
detective controls, (such as completing missing 
data, editing inconsistencies, removing duplicates, 
etc.)  
• Regular feedback to the relevant hospitals to 
correct the data  
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based on the actual process of patient care (from admission to discharge) 
in healthcare facilities as much as possible, and this structure should be 
similar to paper medical record forms so that the clinical team does not 
need to worry about making mistakes in completing them. Studies have 
shown that considering the routine clinical procedures of clinical teams 
and considering it in designing the data collection method in registry 
programs is effective in their success [36]. Therefore, the lifestyle and 
nutrition data elements were excluded by the decision of the steering 
committee, and the necessary modifications were made in the design of 
the forms to make the registration process easier. 
Pilot implementation experiences have shown that in the prospective 
data collection methods, the best approach to ensure the correct and 
complete data collection is to record information at the same time as 
providing care for patients. Secondary use of available data may result in 
missing data. For this reason, prospective data collection was integrated 
into the patients’ care process and data collection forms were placed in 
the patients’ medical records so that the clinical teams could complete 
these forms like other medical reports. 
The pilot implementation showed that some important data, such as 
saturation percentage, were not considered in our data set or the values 
of some fields in the software needed to be standardized and the data 
should be structured as much as possible to increase the common un-
derstanding of the data and improve the quality of information. More 
importantly, the pilot implementation showed that based on new sci-
entific findings and clinical team experiences, the data set and data 
values need constant updating. Lack of support for the required changes 
in the data based on the available scientific evidence [37] can make the 
registry invalid for the clinical team and reduce their cooperation. 
Therefore, during the pilot, several changes were made to the paper 
forms and the registry software. 
Another problem in the implementation of the pilot was the lack of 
proper cooperation of medical staff in completing the information. 
Specifically from the mid of May to the end of June, due to the sudden 
increase in the number of cases and the critical conditions of the hos-
pitals, a severe overload of work was on the medical staff. The reluctance 
of the people to the registry due to the lack of time and increased 
workload [38] is one of the most common problems in registries that 
require appropriate and creative solutions. 
The steering committee used four solutions to solve this problem. 
First of all, we differentiated the role of staff in completing the forms and 
data entry into the software. In this regard, the clinical team only 
completes the forms and other staffs are responsible to enter the data 
into the software. Also, the people in charge of entering the data in the 
software were selected from among the employees of the same hospital. 
This made other hospital staff more cooperative with these staff than the 
outsiders. The second solution was to provide various incentives for the 
medical staff. These incentives include financial payment and partici-
pation in the scientific outputs resulted from the data. Studies have 
shown that financial and non-financial incentives are very effective in 
the successful implementation of registry programs [39]. Our third so-
lution was to get the full support of the senior management of the pilot 
hospitals (director, manager, deputy director of education and research 
department of the hospital and the hospital matrons). Supports of the 
senior managers of the hospitals resulted in less resistance of the medical 
staff to the implementation of the registry. Previous studies have also 
shown that the support of the leaders of an organization in solving 
problems [39] plays a significant role in the success of the registration 
programs. 
The fourth solution was to minimize the manual data collection by 
receiving some data from HIS, MCMC, and MCDPC systems. According 
to previous studies, automatic data entry in a registry system by using 
electronic tools through integrating the registry system with the avail-
able information systems, despite having some complexities and prob-
lems, if implemented properly can increase the speed of data collection 
and reduce the cost of data collection to a great extent [40–43]. Our pilot 
implementation showed that for some data, such as the results of tests 
performed for patients and the medications prescribed, the secondary 
data entry of this information from the patient records is very 
time-consuming and error-prone. Therefore, we automatically import 
laboratory data, medications, and ICD codes from HIS into the registry 
software using web services. Some data, such as demographic data, 
address, and telephone, the date of first symptoms, the date of referral, 
the method of treatment, and the symptoms of the disease, comorbid-
ities, PCR test results, and treatment outcomes are documented in 
MCDPC and MCMC systems. With the cooperation of the IT Management 
of the university, we obtain different outputs from these systems in 
different periods and import these data into the registry software after 
quality control and data correction. Although receiving these outputs 
increases the speed of data collection, due to the manual process, it can 
lead to errors in the data; therefore, it requires data quality assessment. 
5. Conclusion 
In conclusion, disease registry systems can provide valuable infor-
mation about COVID-19 disease to track the prevalence and incidence of 
the disease and conduct the research. In this study, the process of 
implementing the COVID-19 registry in Khuzestan, its pilot imple-
mentation, as well as the challenges and strategies adopted to address 
these challenges were described. If other provinces establish the COVID- 
19 registry, they can start or upgrade their registry based on our expe-
riences gained from this registry. We are planned to continue this reg-
istry by the end of the pandemic and the Ahvaz Jundishapur University 
of Medical Sciences will support financially this registry. Further, ac-
cording to the COVID-19 vaccination program and the use of vaccines, it 
is recommended to expand the registry to include the side effects of 
vaccines and their effectiveness. 
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